secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2022-09-13T23:59:59+00:00
Accession:  0000947871-22-000962
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health elects Jeffrey R. Balser, MD, PhD to Board of Directors
------------------------------------------------------------------

- Dr. Balser has served as President and CEO of Vanderbilt University Medical Center since 2009.
- He guided VUMC's $1.2 billion public debt issuance and legal separation from Vanderbilt University.
- Balser was appointed to the Board's Medical Affairs Committee and deemed independent under NYSE rules.
- His compensation matches other non-employee directors, prorated from September 12, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000094787122000962/0000947871-22-000962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000094787122000962/ss1324378_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-22-000962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer